606 related articles for article (PubMed ID: 36341476)
1. Endogenous opioid systems alterations in pain and opioid use disorder.
Higginbotham JA; Markovic T; Massaly N; Morón JA
Front Syst Neurosci; 2022; 16():1014768. PubMed ID: 36341476
[TBL] [Abstract][Full Text] [Related]
2. Endogenous and Exogenous Opioids in Pain.
Corder G; Castro DC; Bruchas MR; Scherrer G
Annu Rev Neurosci; 2018 Jul; 41():453-473. PubMed ID: 29852083
[TBL] [Abstract][Full Text] [Related]
3. Endogenous Opioids and Their Role in Stem Cell Biology and Tissue Rescue.
Petrocelli G; Pampanella L; Abruzzo PM; Ventura C; Canaider S; Facchin F
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409178
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the antinociceptive and antirewarding profiles of novel bifunctional nociceptin receptor/mu-opioid receptor ligands: implications for therapeutic applications.
Toll L; Khroyan TV; Polgar WE; Jiang F; Olsen C; Zaveri NT
J Pharmacol Exp Ther; 2009 Dec; 331(3):954-64. PubMed ID: 19773529
[TBL] [Abstract][Full Text] [Related]
5. Nociceptin /Orphanin FQ Peptide (NOP) Receptor Modulators: An Update in Structure-Activity Relationships.
Mustazza C; Pieretti S; Marzoli F
Curr Med Chem; 2018; 25(20):2353-2384. PubMed ID: 29332567
[TBL] [Abstract][Full Text] [Related]
6. Endogenous opiates and behavior: 2014.
Bodnar RJ
Peptides; 2016 Jan; 75():18-70. PubMed ID: 26551874
[TBL] [Abstract][Full Text] [Related]
7. Endogenous opiates and behavior: 2020.
Bodnar RJ
Peptides; 2022 May; 151():170752. PubMed ID: 35114317
[TBL] [Abstract][Full Text] [Related]
8. Opioids in chronic pain.
Przewłocki R; Przewłocka B
Eur J Pharmacol; 2001 Oct; 429(1-3):79-91. PubMed ID: 11698029
[TBL] [Abstract][Full Text] [Related]
9. Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies.
Befort K
Front Pharmacol; 2015; 6():6. PubMed ID: 25698968
[TBL] [Abstract][Full Text] [Related]
10. Opioids and opioid receptors; understanding pharmacological mechanisms as a key to therapeutic advances and mitigation of the misuse crisis.
Lambert DG
BJA Open; 2023 Jun; 6():100141. PubMed ID: 37588171
[TBL] [Abstract][Full Text] [Related]
11. Endogenous opiates and behavior: 2012.
Bodnar RJ
Peptides; 2013 Dec; 50():55-95. PubMed ID: 24126281
[TBL] [Abstract][Full Text] [Related]
12. The Nociceptin Receptor as an Emerging Molecular Target for Cocaine Addiction.
Lutfy K; Zaveri NT
Prog Mol Biol Transl Sci; 2016; 137():149-81. PubMed ID: 26810001
[TBL] [Abstract][Full Text] [Related]
13. Aiming at Ideal Therapeutics-MOPr/DOPr or MOPr-DOPr Heteromertargeting Ligand.
Fujita W
Curr Top Med Chem; 2020; 20(31):2843-2851. PubMed ID: 32324516
[TBL] [Abstract][Full Text] [Related]
14. The Role of Mu-Opioids for Reward and Threat Processing in Humans: Bridging the Gap from Preclinical to Clinical Opioid Drug Studies.
Meier IM; Eikemo M; Leknes S
Curr Addict Rep; 2021; 8(2):306-318. PubMed ID: 34722114
[TBL] [Abstract][Full Text] [Related]
15. Nociceptin/orphanin FQ, hedonic state and the response to abused drugs.
Murphy NP
Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Oct; 24(5):295-8. PubMed ID: 15658507
[TBL] [Abstract][Full Text] [Related]
16. Nociceptin/orphanin FQ knockout mice display up-regulation of the opioid receptor-like 1 receptor and alterations in opioid receptor expression in the brain.
Clarke S; Chen Z; Hsu MS; Hill RG; Pintar JE; Kitchen I
Neuroscience; 2003; 117(1):157-68. PubMed ID: 12605902
[TBL] [Abstract][Full Text] [Related]
17. Nicotine and endogenous opioids: neurochemical and pharmacological evidence.
Hadjiconstantinou M; Neff NH
Neuropharmacology; 2011 Jun; 60(7-8):1209-20. PubMed ID: 21108953
[TBL] [Abstract][Full Text] [Related]
18. Persistent inflammatory pain decreases the antinociceptive effects of the mu opioid receptor agonist DAMGO in the locus coeruleus of male rats.
Jongeling AC; Johns ME; Murphy AZ; Hammond DL
Neuropharmacology; 2009; 56(6-7):1017-26. PubMed ID: 19265713
[TBL] [Abstract][Full Text] [Related]
19. Kainic acid-induced seizure activity alters the mRNA expression and G-protein activation of the opioid/nociceptin receptors in the rat brain cortex.
Turunc Bayrakdar E; Bojnik E; Armagan G; Kanit L; Benyhe S; Borsodi A; Yalcin A
Epilepsy Res; 2013 Jul; 105(1-2):13-9. PubMed ID: 23337899
[TBL] [Abstract][Full Text] [Related]
20. Complete knockout of the nociceptin/orphanin FQ receptor in the rat does not induce compensatory changes in mu, delta and kappa opioid receptors.
Homberg JR; Mul JD; de Wit E; Cuppen E
Neuroscience; 2009 Sep; 163(1):308-15. PubMed ID: 19527777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
